The woman may have had a link to another person, who was married to an Ebola survivor and who died a few days previously in Democratic Republic of Congo.

The recent cases come just as Democratic Republic of Congo was set to declare the outbreak’s end.

REGN-EB3 and mAb114 reduced mortality in a clinical trial carried out during the ongoing outbreak in Democratic Republic of Congo.

Deaths attributed to the disease have outpaced those from Ebola this year.

The announcement comes as the country prepares for possible spread of the virus from Democratic Republic of Congo.

The cases, which spread from the outbreak in the DRC, include a five-year-old boy who died.

More than 1,100 people have died in the current Ebola outbreak in Democratic Republic of Congo that started in August 2018.

The person, whose identity has not been revealed, may have been exposed to the virus in Democratic Republic of Congo and is now at the University of Nebraska Medical Center.

The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.

As cases ramp up in Democratic Republic of Congo, the government has banned housing Ebola victims and promises police escorts for health workers at burials.

An accomplished infectious disease scientist, Meyers spent the 1960s treating and studying the condition in central Africa.

The number of cases in Democratic Republic of Congo’s latest outbreak of the virus has now surpassed 100.  

The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.

In response to a new outbreak, health workers will start administering vaccines again soon.

Four of six samples from the North Kivu province have tested positive for the virus.

No new cases have been reported since June 2, the World Health Organizations reports.

The World Health Organization predicts the number of cases in Democratic Republic of Congo will rise up to 300 by July.  

A total of 27 people have died since April, but new funds and the deployment of an experimental vaccine are expected to help contain the virus.

As the virus spreads in Democratic Republic of Congo, the World Health Organization is preparing to immunize people as soon as this week.